Rutaiwan Tohtong

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 15

Top Topics

Duchenne Muscular Dystrophy

Top Venues

Pharmaceuticals (Basel, Switzerland)

Scientific reports

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, Suchada Phimsen, Supisara Sripramote, Jeranan Jantra, Chaiwat Choeiphuk, Somkit Mingphruedhi, Paramin Muangkaew, Narongsak Rungsakulkij, Pongsatorn Tangtawee, Wikran Suragul, Watoo Vassanasiri Farquharson, Kanokpan Wongprasert, Somchai Chutipongtanate, Pimtip Sanvarinda, Marisa Ponpuak, Naravat Poungvarin, Tavan Janvilisri, Tuangporn Suthiphongchai, Kiren Yacqub-Usman, Anna M Grabowska, David Owen Bates, Rutaiwan Tohtong
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, Suchada Phimsen, Supisara Sripramote, Jeranan Jantra, Chaiwat Choeiphuk, Somkit Mingphruedhi, Paramin Muangkaew, Narongsak Rungsakulkij, Pongsatorn Tangtawee, Wikran Suragul, Watoo Vassanasiri Farquharson, Kanokpan Wongprasert, Somchai Chutipongtanate, Pimtip Sanvarinda, Marisa Ponpuak, Naravat Poungvarin, Tavan Janvilisri, Tuangporn Suthiphongchai, Kiren Yacqub-Usman, Anna M Grabowska, David Owen Bates, Rutaiwan Tohtong
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Scientific reports 13 (1) (2023)
Jinchutha Duangdara, Boonyakorn Boonsri, Apinya Sayinta, Kittiya Supradit, Pakpoom Thintharua, Supeecha Kumkate, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Somkit Mingphruedhi, Narongsak Rungsakulkij, Paramin Muangkaew, Pongsatorn Tangtawee, Watoo Vassanasiri, Wikran Suragul, Tavan Janvilisri, Rutaiwan Tohtong, David Owen Bates, Kanokpan Wongprasert
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini -Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Jinchutha Duangdara, Boonyakorn Boonsri, Apinya Sayinta, Kittiya Supradit, Pakpoom Thintharua, Supeecha Kumkate, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Somkit Mingphruedhi, Narongsak Rungsakulkij, Paramin Muangkaew, Pongsatorn Tangtawee, Watoo Vassanasiri, Wikran Suragul, Tavan Janvilisri, Rutaiwan Tohtong, David Owen Bates, Kanokpan Wongprasert
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini -Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Scientific reports 13 (1) (2023)
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Scientific reports 13 (1) (2023)
Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman, Kyaw Zwar Myint, Jitlada Juengsamarn, Poowanai Sarkhampee, Nithi Lertsawatvicha, Jittiyawadee Sripa, Thiti Kuakpaetoon, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Anna M Grabowska, David Owen Bates, Tavan Janvilisri, Rutaiwan Tohtong
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma. Cancers 15 (9) (2023)
Jinchutha Duangdara, Boonyakorn Boonsri, Apinya Sayinta, Kittiya Supradit, Pakpoom Thintharua, Supeecha Kumkate, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Somkit Mingphruedhi, Narongsak Rungsakulkij, Paramin Muangkaew, Pongsatorn Tangtawee, Watoo Vassanasiri, Wikran Suragul, Tavan Janvilisri, Rutaiwan Tohtong, David Owen Bates, Kanokpan Wongprasert
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini -Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Scientific reports 13 (1) (2023)
Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman, Kyaw Zwar Myint, Jitlada Juengsamarn, Poowanai Sarkhampee, Nithi Lertsawatvicha, Jittiyawadee Sripa, Thiti Kuakpaetoon, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Anna M Grabowska, David Owen Bates, Tavan Janvilisri, Rutaiwan Tohtong
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma. Cancers 15 (9) (2023)
Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Sucheewin Krobthong, Patompon Wongtrakoongate, Jittiyawadee Sripa, Panthip Rattanasinganchan, Pornphimon Metheenukul, Rutaiwan Tohtong
In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma. Molecules (Basel, Switzerland) 27 (14) (2022)
Simran Venkatraman, Brinda Balasubramanian, Pisut Pongchaikul, Rutaiwan Tohtong, Somchai Chutipongtanate
Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach. Genes 13 (2) (2022)
Brinda Balasubramanian, Simran Venkatraman, Tavan Janvilisri, Tuangporn Suthiphongchai, Siriporn Jitkaew, Jittiyawadee Sripa, Rutaiwan Tohtong
RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Tavan Janvilisri, Kawin Leelawat, Sittiruk Roytrakul, Atchara Paemanee, Rutaiwan Tohtong
Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach. Disease markers 2015 (2015)